A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control: 一项评估联合使用磺脲与二甲双胍治疗后血糖仍然控制不佳的2型糖尿病患者加用西格列汀治疗后的安全性与有效性的随机临床试验

Highlights In a randomized, placebo‐controlled double‐blind clinical trial occurring primarily in the Asian‐Pacific region, sitagliptin 100 mg/day compared with placebo was generally well tolerated and provided improvement in glycemic control when added to the combination of sulfonylurea and metform...

Full description

Saved in:
Bibliographic Details
Published in:Journal of diabetes 2016-09, Vol.8 (5), p.701-711
Main Authors: Moses, Robert G., Round, Elizabeth, Shentu, Yue, Golm, Gregory T., O'neill, Edward A., Gantz, Ira, Engel, Samuel S., Kaufman, Keith D., Goldstein, Barry J.
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights In a randomized, placebo‐controlled double‐blind clinical trial occurring primarily in the Asian‐Pacific region, sitagliptin 100 mg/day compared with placebo was generally well tolerated and provided improvement in glycemic control when added to the combination of sulfonylurea and metformin in patients with type 2 diabetes.
ISSN:1753-0393
1753-0407
DOI:10.1111/1753-0407.12351